ProQuest Associates III LLC insider trades: Agile Therapeutics (AGRX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where ProQuest Associates III LLC reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2016 | AGRX | ↑ Buy | 393,700 | $6.35 | $2.5M | Indirect | Jan 29, 2016 (2d) |
| Jan 23, 2015 | AGRX | ↑ Buy | 811,966 | $5.85 | $4.8M | Indirect | Jan 23, 2015 (0d) |
| May 29, 2014 | AGRX | ↑ Buy | 1,120,833 | $6.00 | $6.7M | Indirect | Jun 2, 2014 (4d) |
| Mar 31, 2010 | NVDL | ↑ Buy | 4,848,485 | $0.17 | $800K | See | Apr 1, 2010 (1d) |
| Jan 5, 2007 | NVD | ↑ Buy | 763,449 | $1.45 | $1.1M | Direct | Jan 26, 2007 (21d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About ProQuest Associates III LLC's insider trades
ProQuest Associates III LLC is a 10% owner of Agile Therapeutics (AGRX). Since Jan 5, 2007, it has reported 5 open-market purchases worth $15.9M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (7 filings), conversions (3 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AGRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.